Literature DB >> 15069716

Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.

Jun-Gong Zhao1, Gan-Sheng Feng, Xiang-Quan Kong, Xin Li, Ming-Hua Li, Ying-Sheng Cheng.   

Abstract

AIM: To assess the vascularity of hepatocellular carcinoma (HCC) before and after transcatheter arterial chemoembolization (TACE) with the quantitative parameters obtained by first pass perfusion weighted MR imaging (FP-MRI).
METHODS: Seventeen consecutive patients with one to three lesions in liver underwent FP-MRI before treatment. FP-MRI was also performed one, three, six, nine months, and one year after TACE. The baseline signal intensity (S0) of pre-TACE and one month after TACE was analyzed, the vascularity of HCC assessed by steepest slope of the signal intensity versus time curves (SS) was blindly correlated with their DSA feature and clinical outcome. RESULT: No significant difference was found on baseline signal intensity (S0) between pre-TACE and one month after TACE (F=0.309, P=0.583), The SS (mean, 32% per second) of lesion one month after TACE was lower than that of pre-TACE (mean, 69% per second), but with no statistical significance (F=3.067, P=0.092). When local recurrence occurred, the time intensity curves became steeper. The vascularity of HCC before and after TACE graded by SS closely correlated with that by DSA (K=0.453, P<0.05).
CONCLUSION: FP-MRI is a useful criterion for selecting effective interventional treatment for patients with HCC in their initial treatment and during follow up.

Entities:  

Mesh:

Year:  2004        PMID: 15069716      PMCID: PMC4656351          DOI: 10.3748/wjg.v10.i8.1152

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Opacification of the intrahepatic portal veins during CT hepatic arteriography.

Authors:  D Choi; S W Choo; J H Lim; S J Lee; Y S Do; I W Choo
Journal:  J Comput Assist Tomogr       Date:  2001 Mar-Apr       Impact factor: 1.826

2.  Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response.

Authors:  O Ernst; G Sergent; D Mizrahi; O Delemazure; J C Paris; C L'Herminé
Journal:  AJR Am J Roentgenol       Date:  1999-01       Impact factor: 3.959

3.  Proximal arterioportal shunting associated with hepatocellular carcinoma: features revealed by dynamic helical CT.

Authors:  J H Chen; J W Chai; C L Huang; H C Hung; W C Shen; S K Lee
Journal:  AJR Am J Roentgenol       Date:  1999-02       Impact factor: 3.959

Review 4.  Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.

Authors:  Hui-Chuan Sun; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

Authors:  L Lladó; J Virgili; J Figueras; C Valls; J Dominguez; A Rafecas; J Torras; J Fabregat; J Guardiola; E Jaurrieta
Journal:  Cancer       Date:  2000-01-01       Impact factor: 6.860

6.  Changes in rat liver microcirculation after experimental hepatic arterial embolization: comparison of different embolic agents.

Authors:  T Tancredi; P A McCuskey; Z Kan; S Wallace
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

7.  Vascularity of hepatic VX2 tumors of rabbits: assessment with conventional power Doppler US and contrast enhanced harmonic power Doppler US.

Authors:  Wen-Hua Du; Wei-Xiao Yang; Xiang Wang; Xiu-Qin Xiong; Yi Zhou; Tao Li
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

8.  Therapeutic efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology.

Authors:  K Ito; K Honjo; T Fujita; M Matsui; H Awaya; T Matsumoto; N Matsunaga; T Nakanishi
Journal:  J Comput Assist Tomogr       Date:  1995 Mar-Apr       Impact factor: 1.826

9.  [Intratumoral microvessel density and expression of vascular endothelial growth factor in hepatocellular carcinoma after chemoembolization].

Authors:  Guoliang Shao; Jianhua Wang; Kangrong Zhou; Zhiping Yan
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2002-06

10.  [Mechanism of inhibition of tumor angiogenesis by Bletilla colloid: an experimental study].

Authors:  Gan-Sheng Feng; Xin Li; Chuan-Sheng Zheng; Cheng-Kai Zhou; Xi Liu; Han-Ping Wu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2003-03-10
View more
  3 in total

Review 1.  Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Ke Yang; Xiao-Ming Zhang; Lin Yang; Hao Xu; Juan Peng
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

2.  Assessment of hemodynamics in precancerous lesion of hepatocellular carcinoma: evaluation with MR perfusion.

Authors:  Sheng Guan; Wei-Dong Zhao; Kang-Rong Zhou; Wei-Jun Peng; Feng Tang; Jian Mao
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

3.  11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.

Authors:  Sohyun Park; Tae-Sung Kim; Se Hun Kang; Hyun Beom Kim; Joong-Won Park; Seok-Ki Kim
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.